State of evidence

What exists for ALGINAGRAFT™

No bench, preclinical or clinical data for the composition have been published. Results will be posted here as they are produced, with methods, dates and the negative findings alongside the positive ones.

What the literature says about alginate as a biomaterial

Alginate is a polysaccharide extracted from brown algae. The reviews of the field (Lee and Mooney, 2012; Carbohydrate Polymers, 2020; International Journal of Molecular Sciences, 2024) describe it as one of the most studied natural polymers in tissue engineering, used as a cell carrier, scaffold and bioink, forming hydrogels by ionic crosslinking with divalent cations such as calcium, with degradation kinetics that can be tuned by formulation. A 2020 paper on alginate bioinks notes that alginate is widely used in bone tissue engineering «due to its tailorable degradation kinetics, ease of gelation, and possible functionalization with cell adhesive ligands».

The same reviews document the limitations that any alginate-based design has to confront: comparatively poor mechanical properties, a lack of intrinsic cell-adhesive ligands, the absence of alginase in mammals so that degradation depends on ion exchange rather than enzymatic breakdown, and the limited long-term stability of calcium-crosslinked gels in physiological environments.

What is known about alginate in dental bone grafting

Little. A PubMed title-and-abstract search on September 11, 2026 returned 58 papers combining alginate with alveolar bone, 33 with guided bone regeneration, 29 with periodontal regeneration, 4 with sinus or ridge augmentation, and none with socket preservation. The dental work is in vitro or in animal models: a moldable alginate–hydroxyapatite composite in a rabbit mandible (2024), an injectable hydrogel for ridge preservation in rats (2020), and deproteinized bovine bone combined with an alginate gel (BDJ Open, 2020). No human clinical study of alginate as a bone graft carrier was found, and there is no systematic review of alginate in dental bone grafting.

Evidence against the concept

Coathup and colleagues (Journal of Biomedical Materials Research Part B, 2016) compared hydroxyapatite granules with a hydroxyapatite/alginate putty in a sheep model. At six weeks, bone apposition was significantly lower in the putty group; at twelve weeks, new bone was 33.56 ± 3.53% with granules versus 16.69 ± 2.7% with the alginate putty (p = 0.043). The formulation studied is not ALGINAGRAFT™, and the animal model and graft material differ. But the finding — that an alginate carrier slowed bone formation relative to bare granules — is directly relevant. It is treated here as a design constraint to be answered with data, not as a footnote.

What is known about carriers in general

Calder and colleagues (Advanced Healthcare Materials, 2025) reviewed the carriers used in commercial putty-form grafts — collagen, glycerol, carboxymethylcellulose, poloxamer, hyaluronic acid — and reported that most resorb within days, after which the particle scaffold collapses; carboxymethylcellulose is more stable but does not form a three-dimensional scaffold. An earlier review in Acta Biomaterialia (2013) framed the same question in its title: are hydrogels in moldable bone substitutes «sticky excipients or advanced 3-D carriers?». That question is the one the development programme has to answer.

A note on terminology

Two words are avoided on this site on purpose. «Encapsulated»: in implant dentistry, fibrous encapsulation describes a failure mode, and the phrase appears in the literature among the complications of grafting. «Alginate» without qualification: in dental literature the word most often refers to impression material — 217 PubMed title-and-abstract records for alginate with impression material against 54 for alginate with bone graft, of which 7 also mention a dental, alveolar, periodontal or implant context (search of September 11, 2026). Where alginate is meant as a hydrogel matrix for bone graft, this site says so explicitly.

How evidence will be reported here

Each result will carry the method, the date, the sample size and the comparator. Bench data will be labelled as bench data; animal data as animal data. Under the Federal Trade Commission's standard for health-related claims, neither is sufficient to support a claim of clinical benefit, and none will be made until the evidence supports it.